WuXi AppTech IPO Trading Update: What’s up with the Poor Cash Conversion?
WuXi AppTec Co. Ltd. (WUXI HK) is a leading global pharmaceutical R&D outsourcing service provider and the largest in Asia by revenue in 2017....
888 Views
WuXi Apptec (药明康德) IPO: This A+H Listing Will Be Different
Following a fast track A-share listing in May, WuXi AppTec is planning to raise USD 1 bn via an A+H listing. Wuxi AppTec is part of the Wuxi...
1.5k Views
WuXi AppTech IPO Preview: Pharmed Out
WuXi AppTec Co Ltd (603259 CH) is a leading global pharmaceutical R&D outsourcing service provider and the largest in Asia by revenue in 2017....
1.1k Views
ECM Weekly (17 November 2018) - Softbank Corp, Tongcheng-Elong, Junshi Bio, QSR, Sinochem Energy
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
790 Views
Updated Proxy Filed and Q4 Results Released
iKang Healthcare Group (ADR) (KANG US) simultaneously reported its March quarter results and filed the updated proxy for its privatization at...
365 Views